Personalized antibiotic duration for COPD flare-ups
Part of Lungs & breathing clinical trials.
This study is testing a personalized approach to how long antibiotics are given for COPD flare-ups. It aims to see if matching antibiotic duration to each patient's needs is safe and effective, potentially avoiding unnecessary antibiotics.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have COPD, confirmed by a breathing test in the past.
- You are having a flare-up (acute exacerbation) and your doctor thinks you need antibiotics.
- You can give written permission and follow the study plan.
- You do not have a more serious lung condition that needs longer antibiotics (like complicated pneumonia).
- You are not severely immunocompromised, not pregnant/breastfeeding, and have not already been on antibiotics for this flare for >48 hours.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial checks whether using fast test results (PCR from samples, a blood marker called procalcitonin, and sputum appearance) can safely reduce how long you need antibiotics during a severe COPD flare. It may help you receive fewer days of antibiotics while still controlling the infection risk.
This study compares two antibiotics, doxycycline and levofloxacin, to see which works better for treating COPD flare-ups. If you have a COPD exacerbation and haven't taken antibiotics recently, you may be able to join.
This study tests a new approach to reduce flare-ups (sudden worsening of symptoms) in people with COPD. If you've had frequent flare-ups, this trial may help you manage your condition better.
This study looks at whether simple blood tests can help doctors decide if you need antibiotics and steroids for a COPD flare-up. Participating may help tailor your treatment and avoid unnecessary medications.
This trial studies a coordinated (multidisciplinary) care program for people with severe COPD who were recently hospitalized for worsening breathing symptoms. It may help reduce future flare-ups and improve day-to-day breathing by coordinating multiple types of care in a COPD center.
This study tests whether measuring two blood markers (MxA and CRP) can help doctors decide if antibiotics or antiviral drugs are needed for a COPD flare-up. It aims to reduce unnecessary antibiotic use while still treating infections effectively.
Hear when a new COPD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.